03:21 AM EDT, 06/24/2024 (MT Newswires) -- A. Sinclair Dunlop, Director, on June 21, 2024, sold 37,000 shares in Apellis Pharmaceuticals ( APLS ) for $1,451,835. Following the Form 4 filing with the SEC, Dunlop has control over a total of 302,371 shares of the company, with 133,518 shares held directly and 168,853 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000095017024076423/xslF345X03/ownership.xml

Price: 38.50, Change: +0.43, Percent Change: +1.13